Sökning: (WFRF:(Andersson Ove)) srt2:(2005-2009) > Increasing CSF phos...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04842naa a2200757 4500 | |
001 | oai:DiVA.org:oru-4776 | |
003 | SwePub | |
008 | 081127s2008 | |||||||||||000 ||eng| | |
009 | oai:gup.ub.gu.se/96948 | |
009 | oai:DiVA.org:uu-152132 | |
009 | oai:prod.swepub.kib.ki.se:117547618 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-47762 URI |
024 | 7 | a https://doi.org/10.1016/j.neurobiolaging.2007.03.0272 DOI |
024 | 7 | a https://gup.ub.gu.se/publication/969482 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-1521322 URI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1175476182 URI |
040 | a (SwePub)orud (SwePub)gud (SwePub)uud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Andersson, Christinu Karolinska Institutet4 aut |
245 | 1 0 | a Increasing CSF phospho-tau levels during cognitive decline and progression to dementia |
264 | 1 | b Elsevier BV,c 2008 |
338 | a print2 rdacarrier | |
520 | a BACKGROUND: Little is known about longitudinal changes of cerebrospinal fluid (CSF) biomarkers during cognitive decline in neurodegenerative disease progression. OBJECTIVE: To investigate longitudinal changes in CSF biomarkers--total-tau (T-tau), phospho-tau (P-tau) and beta-amyloid (Abeta42)--during cognitive decline. METHODS: Forty memory clinic patients (47.5% females), aged 61.3+/-7.6 (S.D.) years, non-demented at baseline, underwent lumbar puncture and neuropsychological testing at two occasions. Baseline mean MMSE-score was 28.3+/-1.8. Patients were divided into three groups based on baseline memory functioning; severely impaired (SIM), moderately impaired (MIM) and no impairment (NIM). RESULTS: There was a significant increase in P-tau in the SIM-group during follow-up, while P-tau in MIM and NIM did not change. Eighty-three percent of the SIM-patients converted to dementia (80% AD), while most MIM- and NIM-patients remained non-demented. T-tau- and Abeta42-levels did not change in any of the memory groups during follow-up. CONCLUSION: Increasing P-tau levels during cognitive decline and conversion to dementia suggest that P-tau may be useful as a longitudinal marker of the neurodegenerative process. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Neurovetenskaper0 (SwePub)301052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Neurosciences0 (SwePub)301052 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Fysiologi0 (SwePub)301062 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Physiology0 (SwePub)301062 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Geriatrik0 (SwePub)302222 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Geriatrics0 (SwePub)302222 hsv//eng |
653 | a MEDICINE | |
653 | a MEDICIN | |
653 | a Neurobiology | |
653 | a Neurobiologi | |
653 | a Physiology and pharmacology | |
653 | a Fysiologi och farmakologi | |
653 | a Physiology | |
653 | a Fysiologi | |
653 | a Neurology | |
653 | a Neurologi | |
653 | a cerebrospinal-fluid tau | |
653 | a verbal-learning test | |
653 | a alzheimers-disease | |
653 | a follow-up | |
653 | a biochemical marker | |
653 | a lewy bodies | |
653 | a impairment | |
653 | a memory | |
653 | a biomarkers | |
653 | a diagnosis | |
700 | 1 | a Blennow, Kaj,d 1958u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry4 aut0 (Swepub:gu)xbleka |
700 | 1 | a Almkvist, Oveu Karolinska Institutet4 aut |
700 | 1 | a Andreasen, Nielsu Karolinska Institutet4 aut |
700 | 1 | a Engfeldt, Peteru Örebro universitet,Hälsoakademin4 aut0 (Swepub:oru)pet |
700 | 1 | a Johansson, Sven-Erik4 aut |
700 | 1 | a Lindau, Mariau Uppsala universitet,Geriatrik4 aut0 (Swepub:uu)malin088 |
700 | 1 | a Eriksdotter-Jönhagen, Mariau Karolinska Institutet4 aut |
710 | 2 | a Karolinska Institutetb Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi4 org |
773 | 0 | t Neurobiology of Agingd : Elsevier BVg 29:10, s. 1466-1473q 29:10<1466-1473x 0197-4580x 1558-1497 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-4776 |
856 | 4 8 | u https://doi.org/10.1016/j.neurobiolaging.2007.03.027 |
856 | 4 8 | u https://gup.ub.gu.se/publication/96948 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-152132 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:117547618 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.